UBS O'Connor’s AfterNext HealthTech Acquisition Corp AFTR Stock Holding History

UBS O'Connor’s Portfolio AFTR Stock Details AFTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,395,656	Closed	-$14.5M	–	686
2023 Q2	$14.5M	Sell	1,395,656 -31,457	-2%	-$324K	0.3%	50
2023 Q1	$14.6M	Buy	+1,427,113	New	+$14.5M	0.35%	47
2022 Q4	–	Sell	-1,441,079	Closed	-$14.1M	–	597
2022 Q3	$14.1M	Sell	1,441,079 -144,265	-9%	-$1.4M	0.16%	77
2022 Q2	$15.4M	Buy	+1,585,344	New	+$15.4M	0.16%	71
2022 Q1	–	Sell	-1,557,405	Closed	-$15.2M	–	456
2021 Q4	$15.2M	Buy	+1,557,405	New	+$15.1M	0.15%	63

UBS O'Connor's AFTR Position: Q3 2023 in Review

UBS O'Connor sold out of AfterNext HealthTech Acquisition Corp (AFTR) in Q3 2023, closing a stake of 1,395,656 shares — an estimated $14.5M sold.

UBS O'Connor first reported a position in AFTR in Q4 2021 and held it in 5 quarters. The position peaked at $15.4M in Q2 2022. 0 funds tracked by Wall St. Rank hold AFTR as of Q3 2023.

UBS O'Connor reported no remaining AfterNext HealthTech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
UBS O'Connor sold 1,395,656 AfterNext HealthTech Acquisition Corp shares in Q3 2023, an estimated $14.5M.
UBS O'Connor first reported a position in AfterNext HealthTech Acquisition Corp in Q4 2021 and held it in 5 quarters.
UBS O'Connor's AfterNext HealthTech Acquisition Corp position peaked at $15.4M in Q2 2022.
0 funds tracked by Wall St. Rank held AfterNext HealthTech Acquisition Corp as of Q3 2023.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.